Skip to main content
Premium Trial:

Request an Annual Quote

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

In a research letter in JAMA, a team from Harvard Medical School and the London School of Economics and Political Science consider the US Food and Drug Administration's accelerated drug approval pathway, particularly around the performance of required confirmatory trials in relation to the traditional approval or withdrawal processes that followed. Using data for 127 accelerated approvals from 2002 to 2018, the investigators note that confirmatory trials were already underway for 89 of the indications prior to accelerated approval. More than 39 percent of the indications with these early confirmatory trials had progressed to traditional approval or withdrawal in the span of three years, stretching to more than 76 percent by the five-year mark — rates of conversion or withdrawal that outpaced those for indications that had not started on confirmatory trials by the accelerated approval point. "Indications with accelerated approval … that had confirmatory trials started before approval had faster conversion to traditional approval or withdrawal than those that did not, thereby reducing the duration of patient exposure to therapies with uncertain efficacy," they report, though they caution that "there was no statistically significant difference in rates of regulatory outcomes within target timelines by preapproval trial initiation status."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.